- Home
- DNTH vs UAN Comparison
DNTH vs UAN Comparison
Compare DNTH & UAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- UAN
- Stock Information
- Founded
- DNTH 2015
- UAN 2007
- Country
- DNTH United States
- UAN United States
- Employees
- DNTH N/A
- UAN N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- UAN Agricultural Chemicals
- Sector
- DNTH Health Care
- UAN Industrials
- Exchange
- DNTH Nasdaq
- UAN Nasdaq
- Market Cap
- DNTH 724.8M
- UAN 799.2M
- IPO Year
- DNTH N/A
- UAN 2011
- Fundamental
- Price
- DNTH $18.14
- UAN $75.00
- Analyst Decision
- DNTH Strong Buy
- UAN
- Analyst Count
- DNTH 8
- UAN 0
- Target Price
- DNTH $54.33
- UAN N/A
- AVG Volume (30 Days)
- DNTH 362.0K
- UAN 23.2K
- Earning Date
- DNTH 03-11-2025
- UAN 04-28-2025
- Dividend Yield
- DNTH N/A
- UAN 8.98%
- EPS Growth
- DNTH N/A
- UAN N/A
- EPS
- DNTH N/A
- UAN 5.76
- Revenue
- DNTH $6,235,000.00
- UAN $525,323,999.00
- Revenue This Year
- DNTH N/A
- UAN N/A
- Revenue Next Year
- DNTH N/A
- UAN N/A
- P/E Ratio
- DNTH N/A
- UAN $12.99
- Revenue Growth
- DNTH 120.63
- UAN N/A
- 52 Week Low
- DNTH $17.50
- UAN $62.94
- 52 Week High
- DNTH $32.27
- UAN $88.94
- Technical
- Relative Strength Index (RSI)
- DNTH 36.91
- UAN 42.92
- Support Level
- DNTH $17.50
- UAN $74.85
- Resistance Level
- DNTH $20.45
- UAN $75.99
- Average True Range (ATR)
- DNTH 1.67
- UAN 1.46
- MACD
- DNTH -0.22
- UAN 0.08
- Stochastic Oscillator
- DNTH 10.44
- UAN 49.05
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About UAN CVR Partners LP Common Units representing Limited Partner Interests
CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.